ETCTN 10366: A phase 1 study of DNA-PK inhibitor peposertib in combination with hypofractionated radiotherapy for the treatment of locally advanced pancreatic adenocarcinoma

被引：0
|
作者：
Davis, S. Lindsey
Kasi, Anup
Dayyani, Farshid
Ocean, Allyson J.
Chung, Vincent
Al Hallak, Mohammed Najeeb
Fountzilas, Christos
Hu, Junxiao
Murray, Judy
Allegra, Carmen
Gore, Steven
Beumer, Jan Hendrik
Goodman, Karyn A.
机构：
[1] Univ Colorado, Canc Ctr, Aurora, CO USA
[2] Univ Kansas, Canc Ctr, Westwood, KS USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
[4] NewYork Presbyterian Weill Cornell Med Ctr, New York, NY USA
[5] City Hope Comprehens Canc Ctr, Duarte, CA USA
[6] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[7] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[8] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[9] NCI, Bethesda, MD 20892 USA
[10] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[11] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4168
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of celecoxib, irinotecan, and concurrent radiotherapy in the preoperative treatment of locally-advanced pancreatic cancer
    Maheshwari, V
    Ramanathan, RK
    McGrath, K
    Zeh, H
    Burton, S
    Moser, AJ
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S80 - S80
  • [32] A PHASE 1 STUDY OF GEMCITABINE / NAB-PACLITAXEL / S-1 (GAS) COMBINATION NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH LOCALLY-ADVANCED PANCREATIC ADENOCARCINOMA
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Sueda, Taijiro
    GASTROENTEROLOGY, 2017, 152 (05) : S1250 - S1250
  • [33] A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.
    Noel, Marcus Smith
    Philip, Philip Agop
    Tejani, Mohamedtaki Abdulaziz
    Marshall, John
    He, Aiwu Ruth
    Weinberg, Benjamin Adam
    Weiner, Louis M.
    Biswas-Baldwin, Nigel
    Hoke, Frank
    Youssoufian, Hagop
    El-Hariry, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [34] Combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma - a Phase Ib/IIa study
    Schultheis, B.
    Strumberg, D.
    Kuhlmann, J.
    Wolf, M.
    Link, K.
    Seufferlein, T.
    Kaufmann, J.
    Gebhardt, F.
    Khan, M.
    Pelzer, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 64 - 64
  • [35] Concurrent chemoradiotherapy with gemcitabine and S-1 for unresectable locally advanced pancreatic adenocarcinoma: A phase I study
    Ioka, T.
    Fukutake, N.
    Ikezawa, K.
    Tanaka, S.
    Nakamura, S.
    Nishiyama, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942
    Haddock, Michael G.
    Swaminathan, Revathi
    Foster, Nathan R.
    Hauge, Mark D.
    Martenson, James A.
    Camoriano, John K.
    Stella, Philip J.
    Tenglin, Richard C.
    Schaefer, Paul L.
    Moore, Dennis F., Jr.
    Alberts, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2567 - 2572
  • [37] Preoperative intraarterial and intravenous chemo-(iaCT) and sequential hypofractionated radiochemotherapy (RCT) of locally advanced pancreatic adenocarcinoma (T 4; Phase II Study)
    Zimmermann, F.
    Schuhmacher, C.
    Lordick, F.
    Lersch, C.
    Weiss, W.
    Siewert, J. R.
    Molls, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 38 - 38
  • [38] A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy of full-dose gemcitabine in patients with unresectable locally advanced pancreatic carcinoma.
    Nagase, M
    Furuse, J
    Ishii, H
    Kawashima, M
    Ogino, T
    Yoshino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [39] A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma
    Herman, Joseph M.
    Chang, Daniel Tandel
    Goodman, Karyn A.
    Wild, Aaron Tyler
    Laheru, Dan
    Zheng, Lei
    Diaz, Luis A.
    Dung Thi Le
    Raman, Siva P.
    Leal, Jeffrey P.
    Chaudhry, Muhammad Ali
    Sugar, Elizabeth
    Columbo, Laurie Ann
    Tom, Ashlyn
    Limaye, Maneesha R.
    Edil, Barish H.
    Oteiza, Katharine
    Hacker-Prietz, Amy
    Wolfgang, Christopher Lee
    Koong, Albert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Multicenter phase II study of sequential chemotherapy, radiotherapy, and immunotherapy in locally advanced pancreatic (Pa) and biliary tree (Bt) adenocarcinoma (ADK)
    Recchia, F.
    Sica, G.
    Candeloro, G.
    Bisegna, R.
    Necozione, S.
    Bonfili, P.
    Tombolini, V.
    Rea, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345